Search results for "Practice"

showing 10 items of 2812 documents

A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer

2019

PURPOSE: To evaluate the practice patterns among centers and physicians worldwide regarding sentinel lymph node biopsies (SLNB) in cervical cancer (CC) patients. METHOD: A validated 35-item questionnaire regarding SLNB in CC supported by the Gynecologic Cancer Intergroup (GCIG), and sponsored by the North-Eastern German Society of Gynaecologic-Oncology (NOGGO) was sent to all major gynecological cancer societies across the globe for further distribution from October 2015 and continued for a period of 7 months. RESULTS: One hundred and sixty-one institutions from around the world participated. One hundred and six (66%) of the participants were from university centers and one hundred and elev…

medicine.medical_specialtymedicine.medical_treatmentSentinel lymph nodeUterine Cervical NeoplasmsArticle03 medical and health sciences0302 clinical medicineSentinel lymph node biopsySurveys and QuestionnairesMedicineHumansProspective StudiesRadical HysterectomyCervical cancer030219 obstetrics & reproductive medicinebusiness.industryGeneral surgeryInternational surveyObstetrics and GynecologyGeneral MedicineMiddle Agedmedicine.diseaseGynecological cancerClinical Practice030220 oncology & carcinogenesisCervical cancerLymphadenectomyFemaleSurgical educationbusinessInternational survey
researchProduct

Clinical Pitfalls in Diagnosis of Nonmuscle-Invasive Bladder Cancer

2015

Current global economic crisis imposes healthcare system to reduce unnecessary investigations and increase early detection of tumors, to decrease the costs of an advanced disease. Several diagnostic pitfalls may occur dealing with bladder cancer (BC), particularly in nonmuscle-invasive (NMIBC) one. Hematuria, the commonest sign in NMIBC, is often underestimated. Urinary cytology is highly specific for high-grade tumors, but has a low sensitivity for low-grade BC, is operator dependent, and not always obtainable in clinical practice. Numerous urinary tests are available to ameliorate the accuracy of cytology, but none of them is routinly used in urological practice. Ultrasound could hardly …

medicine.medical_specialtymedicine.medical_treatmentUrinary systemCystectomySettore MED/24 - UrologiaCystectomyCytologymedicineHumansNeoplasm InvasivenessSampling (medicine)Bladder cancer Clinical practice Diagnostic pitfalls NMIBC Urothelial tumorBladder cancermedicine.diagnostic_testbusiness.industryCystoscopyGeneral MedicineCystoscopyPathology Reportmedicine.diseaseNeck of urinary bladderEarly DiagnosisTreatment OutcomeUrinary Bladder NeoplasmsRadiologybusinessUrologia Journal
researchProduct

Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population

2020

Platelet aggregation inhibitors (PAI) have widely proven their efficiency for the prevention of ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly multimorbid population and to determine the factors that influence their prescription, including the impact of age, comorbidities and frailty, evaluated through a comprehensive geriatric assessment. This cross-sectional study included all patients admitted to the acute geriatric department of a university hospital from November 2016 to January 2017. We included 304 consecutive hospitalized patients aged 88.7 &plusmn

medicine.medical_specialtymultimorbidityHealth Toxicology and MutagenesisFrail ElderlyPopulationlcsh:MedicineunderuseDiseasefrailty030204 cardiovascular system & hematologyoveruseelderlyArticle03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansMedical history030212 general & internal medicineMedical prescriptionPractice Patterns Physicians'educationplatelet aggregation inhibitorsGeriatric AssessmentAgedAged 80 and overeducation.field_of_studyMini–Mental State Examinationmedicine.diagnostic_test[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologybusiness.industry[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologylcsh:RPublic Health Environmental and Occupational HealthOdds ratiocomprehensive geriatric assessmentConfidence intervalCross-Sectional StudiesagePlatelet aggregation inhibitorFemaleantiplatelet agentsbusinessInternational Journal of Environmental Research and Public Health
researchProduct

Impact of a physician-targeted letter on opioid prescribing.

2020

We study the effect of a physician-targeted nudge letter on opioid prescribing. In May 2017, the Social Insurance Institution of Finland sent a personal information letter to all physicians who had issued a prescription containing at least 100 tablets of paracetamol-codeine combination to a new patient. The aim of the letter was to draw the physicians’ attention to their prescribing practices and to decrease the size of the first codeine prescription. Using individual level register data and a difference-in-differences strategy, we estimate that the letter decreased the average number of tablets purchased by new patients by 12.5 percent and the probability of a first purchase being at least…

medicine.medical_specialtyprescription drugslääkemääräyksetOpioid prescribingSocial insuranceinformation letter03 medical and health sciencesopioiditdifference-in-differencesPhysicians0502 economics and businessmedicinelääketurvallisuusHumans050207 economicsMedical prescriptionlääkäritPractice Patterns Physicians'Finlandohjeetbusiness.industry030503 health policy & servicesHealth Policy05 social sciencesCodeineKansaneläkelaitospalautePublic Health Environmental and Occupational HealthIndividual levelKELADifference in differencesreseptilääkkeetAnalgesics OpioidlääkkeetRegister dataFamily medicineopioid prescribing0305 other medical sciencebusinessPersonally identifiable informationmedicine.drugJournal of health economics
researchProduct

Are biological drugs effective and safe in older severe asthmatics?

2019

Introduction: The treatment of asthma in older ages follows the recommendations of international guidelines for the management of asthma in younger ages, although older age has always represented an exclusion criterion for eligibility to pharmacological trials. This poses a clinical challenge when deciding whether elderly severe asthmatics are candidates for biological drugs. Areas covered: The current article has a narrative structure to review the current literature on efficacy and safety of novel pharmacological drugs against immunoglobulins and interleukins that mediate and orchestrate the main inflammatory pathways in severe asthma, in order to explore whether older subjects (i.e. >…

medicine.medical_specialtypulmonary eosinophilia/drug therapyeducationImmunoglobulinsmonoclonal030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato RespiratorioAnti-asthmatic AgentSeverity of Illness IndexBiological drugs03 medical and health sciences0302 clinical medicineimmune system diseasesInternal medicineSeverity of illnessImmunoglobulinHumansMedicineAnti-Asthmatic AgentPharmacology (medical)Age FactorAnti-Asthmatic AgentsAsthmaAgedRandomized Controlled Trials as TopicBiological ProductsAsthma/drug therapybiologyhumanizedbusiness.industryInterleukinsAge FactorsGeneral MedicineInterleukinmedicine.diseaseAsthmarespiratory tract diseasesantibodie030220 oncology & carcinogenesisMonoclonalPractice Guidelines as Topicbiology.proteinBiological Productanti-asthmatic agents/pharmacologyAntibodybusinessHuman
researchProduct

<p>Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Sys…

2020

Abstract Neuroendocrine tumors (NETs) of the lung are well-differentiated neuroendocrine neoplasms (NENs) with a heterogeneous clinical behaviour. Unlike gastroenteropancreatic NENs where therapeutic armamentarium clearly increased over the last decade, everolimus represented the only clinical practical innovation for lung NET patients over the last years. Therefore, for lung NETs, a multidisciplinary discussion within a dedicated team remains critical for an adequate decision-making. Although the main regulatory authorities considered the everolimus-related evidence is enough to approve the drug in advanced lung NETs, several clinical features deserve to be discussed. In this review, we sy…

medicine.medical_specialtytargeted agentsEverolimusLungbusiness.industryContext (language use)Reviewrespiratory systemNeuroendocrine tumorseverolimusmedicine.diseaseatypical carcinoidClinical Practicelung NETtypical carcinoidmedicine.anatomical_structureOncologymammalian target of rapamycin (mTOR) inhibitormedicineTypical carcinoidIntensive care medicinebusinessAtypical carcinoidClinical evaluationmedicine.drugLung Cancer: Targets and Therapy
researchProduct

Managing Peripheral Artery Disease in Diabetic Patients: A Questionnaire Survey from Vascular Centers of the Mediterranean Federation for the Advanci…

2020

Background The Mediterranean Federation for the Advancing of Vascular Surgery (MeFAVS) was founded on October 1, 2018, to enhance cooperation among vascular professionals within Mediterranean countries. Due to its prominent social and economic impact on national health systems, diabetic arteriopathy has been selected as the very first topic to be investigated by the federation. Methods MeFAVS members were asked to reply to a questionnaire on the management of diabetic ischemic foot. Results were collected and analyzed statistically. The questionnaire consisted of 15 multiple choice answers regarding diabetic foot (DF) diagnosis and treatment. The questionnaire was submitted to 21 centers on…

medicine.medical_treatmentPsychological intervention030204 cardiovascular system & hematologyvascular surgerySettore MED/22 - Chirurgia Vascolare030218 nuclear medicine & medical imagingWound care0302 clinical medicineIschemiaPractice Patterns Physicians'Response rate (survey)Practice Patterns Nurses'diabetesMediterranean RegionEndovascular Proceduresvascular medicineGeneral MedicineTreatment OutcomeCardiology and Cardiovascular MedicineVascular Surgical Proceduresdiabetic footmanagementSpecializationReoperationmedicine.medical_specialtyRevascularizationNurse's RoleAmputation Surgical03 medical and health sciencesperipheral arterial diseaseMediterranean Seamedicineperipheral arterial disease; diabetes; vascular medicine; vascular surgeryHumansTrainingHealthcare DisparitiesEndovascular Surgery; Mediterranean Sea; Training; Vascular SurgeryPhysician's RolePatient Care TeamWound Healingbusiness.industryGeneral surgeryVascular surgerymedicine.diseaseDiabetic footAmputationHealth Care SurveysOrthopedic surgeryEndovascular SurgerySurgerybusinesswound careAnnals of Vascular Surgery
researchProduct

Is COVID‐19 infection more severe in kidney transplant recipients?

2021

International audience; There are no studies which have compared the risk of severe Covid-19 and related mortality between transplant recipients and non-transplant patients. We enrolled two groups of patients hospitalized for Covid-19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a single-center cohort of non-transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covid-19 or mortality. Severe Covid-19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death.Transplant recipients were younger and had more comorbidities compared to…

medicine.medical_treatment[SDV]Life Sciences [q-bio]MESH: Registries*AucunMESH: Comorbidity030230 surgerylaw.inventionchemistry.chemical_compound0302 clinical medicinelawcardiovascular diseaseMESH: Risk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesclinical research / practiceImmunology and AllergyCumulative incidencePharmacology (medical)kidney transplantation / nephrologyMESH: IncidenceMESH: AgedUnivariate analysisMESH: France / epidemiologyMESH: Middle AgedMESH: Transplant Recipients / statistics & numerical data*Acute kidney injuryIntensive care unit3. Good healthMESH: COVID-19 / epidemiologyCohort[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesglomerular filtration rate (GFR)kidney failure / injurymedicine.medical_specialtyinfection and infectious agents - viralinfectious diseaseBrief CommunicationMESH: Graft Rejection / prevention & control03 medical and health sciencesInternal medicineDiabetes mellitusMESH: Severity of Illness IndexMESH: COVID-19 / diagnosis*medicineHumansMESH: SARS-CoV-2Mechanical ventilationCreatinineTransplantationMESH: Humansbusiness.industrySARS-CoV-2MESH: Graft Rejection / epidemiology*COVID-19MESH: Retrospective Studiesmedicine.diseaseKidney TransplantationTransplant RecipientsMESH: Maleimmunosuppressive regimensMESH: Immunosuppressive Agents / therapeutic useMESH: Pandemics*MESH: Propensity Score*chemistryReinfectionMESH: Immunosuppression / methodsMESH: Intensive Care UnitsbusinessMESH: FemaleMESH: Kidney Transplantation*
researchProduct

Memory in Action – Performative Practices in a Dispute about the Past: Serbia and Croatia at the Turn of the 20th and 21st Century

2019

The article is an attempt to combine in one reflection the elements of two directions of critical thinking: discursive and performative. The starting point of the analysis is the assumption (derived from beliefs common in pre-performative times) that every space (including a city’s territory) can be treated as a text. This means that both static artifacts and activities in a given space communicate a certain message and can be seen as signs or symbols that refer to something outside of them. Our reflection focuses on practices in which the performative potential is fully revealed and which can be interpreted as a kind of rebellion against the present reality and official policies of memory.…

memoryperformative practicesCroatiadiscourseSerbiaSlavia Meridionalis
researchProduct

Chronic Mesenteric Ischemia: Critical review and guidelines for management

2011

Background CMI is caused by chronic occlusive disease of mesenteric arteries. In such an uncommon disease, clear recommendations are strongly needed. Unfortunately, treatment options for symptomatic CMI are still controversial and no guidelines exist. Methods A systematic literature review of the last 25-years was conducted through MEDLINE, Embase, and Cochrane Review/Trials register to identify studies reporting on CMI treatment with more than 10 patients. Primary outcomes were perioperative mortality and morbidity rates. Secondary outcomes were survival rates, primary and secondary patency rates, vessels treated, CMI recurrence, follow-up (FU), technical success (TS), and in-hospital leng…

mesenteric chronic ischemia vascular surgeryPediatricsmedicine.medical_specialtyTime FactorsMEDLINE610 Medicine & healthDiseaseSettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineIschemiaRecurrenceRisk FactorsMesenteric Vascular OcclusionmedicineHumansVascular PatencyVascular DiseasesSurvival rateVascular PatencyChi-Square Distributionbusiness.industry10042 Clinic for Diagnostic and Interventional RadiologyPatient Selection10031 Clinic for AngiologyEndovascular ProceduresGeneral MedicinePerioperativeLength of Staymedicine.disease10020 Clinic for Cardiac Surgery2746 SurgeryTreatment OutcomeSystematic reviewMesenteric ischemiaMesenteric IschemiaPractice Guidelines as TopicSurgeryCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresChi-squared distributionAlgorithms
researchProduct